solo para uso en investigación
Cat. No.S1108
| Dianas relacionadas | EGFR VEGFR PDGFR FGFR c-Met Src MEK CSF-1R FLT3 HER2 |
|---|---|
| Otros ALK Inhibidores | GSK1838705A Repotrectinib (TPX-0005) AZD3463 Ensartinib dihydrochloride AP26113-analog (ALK-IN-1) ASP3026 NVL-655 (Neladalkib) Envonalkib Belizatinib (TSR-011) HG-14-10-04 |
| Líneas celulares | Tipo de ensayo | Concentración | Tiempo de incubación | Formulación | Descripción de la actividad | PMID |
|---|---|---|---|---|---|---|
| SCC-3 | Growth Inhibition Assay | IC50=0.0000603 μM | ||||
| SF539 | Growth Inhibition Assay | IC50=0.000564 μM | ||||
| DEL | Growth Inhibition Assay | IC50=0.000927 μM | ||||
| NB1 | Growth Inhibition Assay | IC50=0.00162 μM | ||||
| SR | Growth Inhibition Assay | IC50=0.00277 μM | ||||
| KARPAS-299 | Growth Inhibition Assay | IC50=0.02384 μM | ||||
| MHH-CALL-2 | Growth Inhibition Assay | IC50=0.02952 μM | ||||
| SU-DHL-1 | Growth Inhibition Assay | IC50=0.04865 μM | ||||
| A4-Fuk | Growth Inhibition Assay | IC50=0.05565 μM | ||||
| EW-1 | Growth Inhibition Assay | IC50=0.10256 μM | ||||
| NOS-1 | Growth Inhibition Assay | IC50=0.10294 μM | ||||
| EW-16 | Growth Inhibition Assay | IC50=0.10568 μM | ||||
| TE-11 | Growth Inhibition Assay | IC50=0.16096 μM | ||||
| SW982 | Growth Inhibition Assay | IC50=0.16478 μM | ||||
| LAN-6 | Growth Inhibition Assay | IC50=0.17443 μM | ||||
| MZ1-PC | Growth Inhibition Assay | IC50=0.17835 μM | ||||
| KS-1 | Growth Inhibition Assay | IC50=0.19343 μM | ||||
| PSN1 | Growth Inhibition Assay | IC50=0.19631 μM | ||||
| LC-2-ad | Growth Inhibition Assay | IC50=0.19692 μM | ||||
| COLO-320-HSR | Growth Inhibition Assay | IC50=0.19776 μM | ||||
| OPM-2 | Growth Inhibition Assay | IC50=0.22669 μM | ||||
| SK-NEP-1 | Growth Inhibition Assay | IC50=0.23524 μM | ||||
| ALL-PO | Growth Inhibition Assay | IC50=0.24524 μM | ||||
| CMK | Growth Inhibition Assay | IC50=0.2553 μM | ||||
| NCI-H1648 | Growth Inhibition Assay | IC50=0.27855 μM | ||||
| SIG-M5 | Growth Inhibition Assay | IC50=0.29159 μM | ||||
| TGBC24TKB | Growth Inhibition Assay | IC50=0.30218 μM | ||||
| DOHH-2 | Growth Inhibition Assay | IC50=0.31204 μM | ||||
| NB69 | Growth Inhibition Assay | IC50=0.31787 μM | ||||
| MFH-ino | Growth Inhibition Assay | IC50=0.32523 μM | ||||
| KP-N-RT-BM-1 | Growth Inhibition Assay | IC50=0.33123 μM | ||||
| MONO-MAC-6 | Growth Inhibition Assay | IC50=0.33291 μM | ||||
| ATN-1 | Growth Inhibition Assay | IC50=0.33303 μM | ||||
| NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=0.33396 μM | ||||
| L-540 | Growth Inhibition Assay | IC50=0.36988 μM | ||||
| GB-1 | Growth Inhibition Assay | IC50=0.38867 μM | ||||
| MV-4-11 | Growth Inhibition Assay | IC50=0.39446 μM | ||||
| KG-1 | Growth Inhibition Assay | IC50=0.39561 μM | ||||
| OVCAR-4 | Growth Inhibition Assay | IC50=0.40569 μM | ||||
| NEC8 | Growth Inhibition Assay | IC50=0.41292 μM | ||||
| SK-MM-2 | Growth Inhibition Assay | IC50=0.41609 μM | ||||
| TE-8 | Growth Inhibition Assay | IC50=0.4288 μM | ||||
| 697 | Growth Inhibition Assay | IC50=0.43215 μM | ||||
| NB14 | Growth Inhibition Assay | IC50=0.43826 μM | ||||
| GDM-1 | Growth Inhibition Assay | IC50=0.47116 μM | ||||
| HUTU-80 | Growth Inhibition Assay | IC50=0.47375 μM | ||||
| HL-60 | Growth Inhibition Assay | IC50=0.48142 μM | ||||
| OCI-AML2 | Growth Inhibition Assay | IC50=0.48328 μM | ||||
| ML-2 | Growth Inhibition Assay | IC50=0.49031 μM | ||||
| ES4 | Growth Inhibition Assay | IC50=0.49109 μM | ||||
| NCI-H747 | Growth Inhibition Assay | IC50=0.4989 μM | ||||
| RL95-2 | Growth Inhibition Assay | IC50=0.50112 μM | ||||
| TE-15 | Growth Inhibition Assay | IC50=0.51124 μM | ||||
| TE-12 | Growth Inhibition Assay | IC50=0.53349 μM | ||||
| LB1047-RCC | Growth Inhibition Assay | IC50=0.54549 μM | ||||
| LB831-BLC | Growth Inhibition Assay | IC50=0.55023 μM | ||||
| NCI-H1355 | Growth Inhibition Assay | IC50=0.55184 μM | ||||
| CTV-1 | Growth Inhibition Assay | IC50=0.55624 μM | ||||
| RXF393 | Growth Inhibition Assay | IC50=0.55794 μM | ||||
| SW872 | Growth Inhibition Assay | IC50=0.56724 μM | ||||
| MPP-89 | Growth Inhibition Assay | IC50=0.57884 μM | ||||
| RPMI-8226 | Growth Inhibition Assay | IC50=0.63526 μM | ||||
| LS-1034 | Growth Inhibition Assay | IC50=0.6358 μM | ||||
| SJSA-1 | Growth Inhibition Assay | IC50=0.63725 μM | ||||
| HOP-62 | Growth Inhibition Assay | IC50=0.65033 μM | ||||
| KGN | Growth Inhibition Assay | IC50=0.66168 μM | ||||
| D-336MG | Growth Inhibition Assay | IC50=0.66169 μM | ||||
| LS-411N | Growth Inhibition Assay | IC50=0.67462 μM | ||||
| TE-1 | Growth Inhibition Assay | IC50=0.69074 μM | ||||
| LB996-RCC | Growth Inhibition Assay | IC50=0.69389 μM | ||||
| TE-10 | Growth Inhibition Assay | IC50=0.71496 μM | ||||
| NCI-SNU-16 | Growth Inhibition Assay | IC50=0.72664 μM | ||||
| ES8 | Growth Inhibition Assay | IC50=0.74975 μM | ||||
| COLO-800 | Growth Inhibition Assay | IC50=0.76695 μM | ||||
| ES6 | Growth Inhibition Assay | IC50=0.77559 μM | ||||
| L-363 | Growth Inhibition Assay | IC50=0.82375 μM | ||||
| NMC-G1 | Growth Inhibition Assay | IC50=0.83233 μM | ||||
| LU-134-A | Growth Inhibition Assay | IC50=0.83912 μM | ||||
| SF268 | Growth Inhibition Assay | IC50=0.84042 μM | ||||
| KARPAS-45 | Growth Inhibition Assay | IC50=0.84263 μM | ||||
| TGW | Growth Inhibition Assay | IC50=0.85863 μM | ||||
| CHP-126 | Growth Inhibition Assay | IC50=0.85957 μM | ||||
| MOLT-16 | Growth Inhibition Assay | IC50=0.87589 μM | ||||
| LB771-HNC | Growth Inhibition Assay | IC50=0.89757 μM | ||||
| NALM-6 | Growth Inhibition Assay | IC50=0.90739 μM | ||||
| GCIY | Growth Inhibition Assay | IC50=0.95526 μM | ||||
| IST-MES1 | Growth Inhibition Assay | IC50=0.98824 μM | ||||
| LB2241-RCC | Growth Inhibition Assay | IC50=0.9884 μM | ||||
| BL-70 | Growth Inhibition Assay | IC50=0.99535 μM | ||||
| NB17 | Growth Inhibition Assay | IC50=1.00639 μM | ||||
| LXF-289 | Growth Inhibition Assay | IC50=1.03076 μM | ||||
| TK10 | Growth Inhibition Assay | IC50=1.05063 μM | ||||
| K5 | Growth Inhibition Assay | IC50=1.06274 μM | ||||
| NCI-H716 | Growth Inhibition Assay | IC50=1.07259 μM | ||||
| HCE-T | Growth Inhibition Assay | IC50=1.08819 μM | ||||
| GI-1 | Growth Inhibition Assay | IC50=1.09798 μM | ||||
| KARPAS-422 | Growth Inhibition Assay | IC50=1.10022 μM | ||||
| TE-9 | Growth Inhibition Assay | IC50=1.11328 μM | ||||
| SF126 | Growth Inhibition Assay | IC50=1.11568 μM | ||||
| BB30-HNC | Growth Inhibition Assay | IC50=1.13112 μM | ||||
| NCI-H1304 | Growth Inhibition Assay | IC50=1.13338 μM | ||||
| HEL | Growth Inhibition Assay | IC50=1.14895 μM | ||||
| HAL-01 | Growth Inhibition Assay | IC50=1.15283 μM | ||||
| SK-LMS-1 | Growth Inhibition Assay | IC50=1.15974 μM | ||||
| SW954 | Growth Inhibition Assay | IC50=1.19567 μM | ||||
| D-283MED | Growth Inhibition Assay | IC50=1.22379 μM | ||||
| NCI-H1882 | Growth Inhibition Assay | IC50=1.2389 μM | ||||
| GI-ME-N | Growth Inhibition Assay | IC50=1.25208 μM | ||||
| SK-PN-DW | Growth Inhibition Assay | IC50=1.26348 μM | ||||
| C2BBe1 | Growth Inhibition Assay | IC50=1.29117 μM | ||||
| A704 | Growth Inhibition Assay | IC50=1.32689 μM | ||||
| KALS-1 | Growth Inhibition Assay | IC50=1.3408 μM | ||||
| ETK-1 | Growth Inhibition Assay | IC50=1.34489 μM | ||||
| LB647-SCLC | Growth Inhibition Assay | IC50=1.34986 μM | ||||
| OCUB-M | Growth Inhibition Assay | IC50=1.36143 μM | ||||
| NCI-H720 | Growth Inhibition Assay | IC50=1.36378 μM | ||||
| NB13 | Growth Inhibition Assay | IC50=1.37293 μM | ||||
| GR-ST | Growth Inhibition Assay | IC50=1.38757 μM | ||||
| DU-4475 | Growth Inhibition Assay | IC50=1.45853 μM | ||||
| HCC2157 | Growth Inhibition Assay | IC50=1.46659 μM | ||||
| RKO | Growth Inhibition Assay | IC50=1.49922 μM | ||||
| LS-123 | Growth Inhibition Assay | IC50=1.51594 μM | ||||
| NCI-H69 | Growth Inhibition Assay | IC50=1.55811 μM | ||||
| SW962 | Growth Inhibition Assay | IC50=1.5613 μM | ||||
| PF-382 | Growth Inhibition Assay | IC50=1.5696 μM | ||||
| A101D | Growth Inhibition Assay | IC50=1.57113 μM | ||||
| NB10 | Growth Inhibition Assay | IC50=1.57392 μM | ||||
| NB5 | Growth Inhibition Assay | IC50=1.58476 μM | ||||
| HCE-4 | Growth Inhibition Assay | IC50=1.6085 μM | ||||
| HT-144 | Growth Inhibition Assay | IC50=1.6319 μM | ||||
| NCI-H524 | Growth Inhibition Assay | IC50=1.64307 μM | ||||
| NKM-1 | Growth Inhibition Assay | IC50=1.6866 μM | ||||
| KURAMOCHI | Growth Inhibition Assay | IC50=1.69573 μM | ||||
| NCI-H187 | Growth Inhibition Assay | IC50=1.70036 μM | ||||
| U-266 | Growth Inhibition Assay | IC50=1.73842 μM | ||||
| BL-41 | Growth Inhibition Assay | IC50=1.76272 μM | ||||
| SK-N-DZ | Growth Inhibition Assay | IC50=1.78309 μM | ||||
| Daudi | Growth Inhibition Assay | IC50=1.78967 μM | ||||
| CPC-N | Growth Inhibition Assay | IC50=1.85096 μM | ||||
| EM-2 | Growth Inhibition Assay | IC50=1.851 μM | ||||
| HCC1187 | Growth Inhibition Assay | IC50=1.86241 μM | ||||
| LP-1 | Growth Inhibition Assay | IC50=1.87143 μM | ||||
| CAS-1 | Growth Inhibition Assay | IC50=1.98299 μM | ||||
| NB7 | Growth Inhibition Assay | IC50=2.00555 μM | ||||
| VA-ES-BJ | Growth Inhibition Assay | IC50=2.01513 μM | ||||
| SNU-C2B | Growth Inhibition Assay | IC50=2.03351 μM | ||||
| LOXIMVI | Growth Inhibition Assay | IC50=2.06786 μM | ||||
| NCI-H1581 | Growth Inhibition Assay | IC50=2.11559 μM | ||||
| IST-SL2 | Growth Inhibition Assay | IC50=2.12445 μM | ||||
| NOMO-1 | Growth Inhibition Assay | IC50=2.17683 μM | ||||
| TE-6 | Growth Inhibition Assay | IC50=2.1905 μM | ||||
| NCI-H526 | Growth Inhibition Assay | IC50=2.19141 μM | ||||
| MSTO-211H | Growth Inhibition Assay | IC50=2.20041 μM | ||||
| LS-513 | Growth Inhibition Assay | IC50=2.22269 μM | ||||
| NCI-SNU-1 | Growth Inhibition Assay | IC50=2.33256 μM | ||||
| BB65-RCC | Growth Inhibition Assay | IC50=2.37493 μM | ||||
| GT3TKB | Growth Inhibition Assay | IC50=2.39972 μM | ||||
| OS-RC-2 | Growth Inhibition Assay | IC50=2.42341 μM | ||||
| NCI-H2126 | Growth Inhibition Assay | IC50=2.43674 μM | ||||
| SK-UT-1 | Growth Inhibition Assay | IC50=2.47467 μM | ||||
| DMS-114 | Growth Inhibition Assay | IC50=2.61524 μM | ||||
| ONS-76 | Growth Inhibition Assay | IC50=2.63641 μM | ||||
| 8-MG-BA | Growth Inhibition Assay | IC50=2.65414 μM | ||||
| BOKU | Growth Inhibition Assay | IC50=2.72764 μM | ||||
| LAMA-84 | Growth Inhibition Assay | IC50=2.79912 μM | ||||
| ES1 | Growth Inhibition Assay | IC50=2.81804 μM | ||||
| NCI-H1395 | Growth Inhibition Assay | IC50=2.82012 μM | ||||
| A388 | Growth Inhibition Assay | IC50=2.9617 μM | ||||
| NCCIT | Growth Inhibition Assay | IC50=3.08862 μM | ||||
| HD-MY-Z | Growth Inhibition Assay | IC50=3.13203 μM | ||||
| NCI-H510A | Growth Inhibition Assay | IC50=3.18943 μM | ||||
| NCI-N87 | Growth Inhibition Assay | IC50=3.2002 μM | ||||
| SCLC-21H | Growth Inhibition Assay | IC50=3.26859 μM | ||||
| SH-4 | Growth Inhibition Assay | IC50=3.28797 μM | ||||
| QIMR-WIL | Growth Inhibition Assay | IC50=3.32849 μM | ||||
| KM12 | Growth Inhibition Assay | IC50=3.33544 μM | ||||
| ST486 | Growth Inhibition Assay | IC50=3.53883 μM | ||||
| HC-1 | Growth Inhibition Assay | IC50=3.62028 μM | ||||
| BV-173 | Growth Inhibition Assay | IC50=3.64088 μM | ||||
| EW-24 | Growth Inhibition Assay | IC50=3.66434 μM | ||||
| LU-65 | Growth Inhibition Assay | IC50=3.6871 μM | ||||
| ECC4 | Growth Inhibition Assay | IC50=3.7756 μM | ||||
| ARH-77 | Growth Inhibition Assay | IC50=4.11067 μM | ||||
| BC-3 | Growth Inhibition Assay | IC50=4.13068 μM | ||||
| SNB75 | Growth Inhibition Assay | IC50=4.2619 μM | ||||
| MEG-01 | Growth Inhibition Assay | IC50=4.27419 μM | ||||
| NCI-H1417 | Growth Inhibition Assay | IC50=4.28443 μM | ||||
| MDA-MB-134-VI | Growth Inhibition Assay | IC50=4.30601 μM | ||||
| Becker | Growth Inhibition Assay | IC50=4.47336 μM | ||||
| DMS-153 | Growth Inhibition Assay | IC50=4.66475 μM | ||||
| TGBC1TKB | Growth Inhibition Assay | IC50=4.68515 μM | ||||
| EW-3 | Growth Inhibition Assay | IC50=4.76248 μM | ||||
| KE-37 | Growth Inhibition Assay | IC50=4.86196 μM | ||||
| NCI-H23 | Growth Inhibition Assay | IC50=4.87227 μM | ||||
| MC116 | Growth Inhibition Assay | IC50=4.94126 μM | ||||
| NH-12 | Growth Inhibition Assay | IC50=4.96439 μM | ||||
| CTB-1 | Growth Inhibition Assay | IC50=4.97721 μM | ||||
| KM-H2 | Growth Inhibition Assay | IC50=5.05323 μM | ||||
| MOLT-4 | Growth Inhibition Assay | IC50=5.1183 μM | ||||
| NCI-H2141 | Growth Inhibition Assay | IC50=5.14268 μM | ||||
| EB-3 | Growth Inhibition Assay | IC50=5.17504 μM | ||||
| NCI-H1522 | Growth Inhibition Assay | IC50=5.26322 μM | ||||
| MRK-nu-1 | Growth Inhibition Assay | IC50=5.43633 μM | ||||
| no-11 | Growth Inhibition Assay | IC50=5.47087 μM | ||||
| CESS | Growth Inhibition Assay | IC50=5.58034 μM | ||||
| KMOE-2 | Growth Inhibition Assay | IC50=5.58659 μM | ||||
| REH | Growth Inhibition Assay | IC50=6.25618 μM | ||||
| KU812 | Growth Inhibition Assay | IC50=6.42791 μM | ||||
| SK-N-FI | Growth Inhibition Assay | IC50=6.60674 μM | ||||
| MMAC-SF | Growth Inhibition Assay | IC50=7.06492 μM | ||||
| RCC10RGB | Growth Inhibition Assay | IC50=7.22977 μM | ||||
| NCI-H322M | Growth Inhibition Assay | IC50=7.33335 μM | ||||
| NB6 | Growth Inhibition Assay | IC50=7.54899 μM | ||||
| MN-60 | Growth Inhibition Assay | IC50=7.69215 μM | ||||
| NCI-H1092 | Growth Inhibition Assay | IC50=8.01734 μM | ||||
| EKVX | Growth Inhibition Assay | IC50=8.47066 μM | ||||
| D-263MG | Growth Inhibition Assay | IC50=8.55396 μM | ||||
| NCI-H209 | Growth Inhibition Assay | IC50=8.64006 μM | ||||
| IST-SL1 | Growth Inhibition Assay | IC50=8.89892 μM | ||||
| ACN | Growth Inhibition Assay | IC50=9.19157 μM | ||||
| MHH-PREB-1 | Growth Inhibition Assay | IC50=9.21219 μM | ||||
| EW-11 | Growth Inhibition Assay | IC50=9.65396 μM | ||||
| KASUMI-1 | Growth Inhibition Assay | IC50=9.7877 μM | ||||
| KINGS-1 | Growth Inhibition Assay | IC50=10.2347 μM | ||||
| EVSA-T | Growth Inhibition Assay | IC50=10.3192 μM | ||||
| DSH1 | Growth Inhibition Assay | IC50=10.3972 μM | ||||
| COLO-824 | Growth Inhibition Assay | IC50=10.8669 μM | ||||
| K052 | Growth Inhibition Assay | IC50=10.9322 μM | ||||
| SK-MEL-2 | Growth Inhibition Assay | IC50=10.9939 μM | ||||
| Haga clic para ver más datos experimentales de líneas celulares | ||||||
| Peso molecular | 614.2 | Fórmula | C30H40ClN7O3S |
Almacenamiento (Desde la fecha de recepción) | |
|---|---|---|---|---|---|
| Nº CAS | 761439-42-3 | Descargar SDF | Almacenamiento de soluciones madre |
|
|
| Sinónimos | N/A | Smiles | CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC | ||
|
In vitro |
DMSO
: 10 mg/mL
(16.28 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Paso 1: Introduzca la información a continuación (Recomendado: Un animal adicional para tener en cuenta la pérdida durante el experimento)
Paso 2: Introduzca la formulación in vivo (Esto es solo la calculadora, no la formulación. Por favor, contáctenos primero si no hay una formulación in vivo en la sección de Solubilidad.)
Resultados del cálculo:
Concentración de trabajo: mg/ml;
Método para preparar el líquido maestro de DMSO: mg fármaco predissuelto en μL DMSO ( Concentración del líquido maestro mg/mL, Por favor, contáctenos primero si la concentración excede la solubilidad del DMSO del lote del fármaco. )
Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadirμL PEG300, mezclar y clarificar, luego añadirμL Tween 80, mezclar y clarificar, luego añadir μL ddH2O, mezclar y clarificar.
Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadir μL Aceite de maíz, mezclar y clarificar.
Nota: 1. Por favor, asegúrese de que el líquido esté claro antes de añadir el siguiente disolvente.
2. Asegúrese de añadir el (los) disolvente(s) en orden. Debe asegurarse de que la solución obtenida, en la adición anterior, sea una solución clara antes de proceder a añadir el siguiente disolvente. Se pueden utilizar métodos físicos como el vórtice, el ultrasonido o el baño de agua caliente para ayudar a la disolución.
| Targets/IC50/Ki |
ALK
(Cell lines) 2-10 nM
|
|---|---|
| In vitro |
TAE684 (NVP-TAE684) no presenta una reactividad cruzada significativa contra otras quinasas. Este compuesto inhibe potentemente la proliferación de células Ba/F3 NPM-ALK con una IC50 de 3 nM, sin afectar la supervivencia de las células Ba/F3 incluso a 1 µM. También inhibe la proliferación de líneas celulares ALCL humanas que expresan NPM-ALK, incluyendo Karpas-299 y SU-DHL-1, con una IC50 de 2–5 nM. El modelado molecular revela que L258 puede ser uno de los principales determinantes de la selectividad de la quinasa para este químico. Su tratamiento resulta en una inhibición rápida y sostenida de la fosforilación de NPM-ALK. El compuesto induce apoptosis y detención en fase G1 en células Ba/F3 que expresan NPM-ALK y líneas celulares de pacientes con ALCL. Supera notablemente la resistencia en células H3122 CR, que albergan el oncogén de fusión EML4-ALK, disminuyendo el crecimiento celular, suprimiendo la fosforilación de ALK e induciendo apoptosis. El crecimiento de neuritas inducido por la expresión del mutante mALK R1279Q podría ser completamente inhibido por este compuesto a 30 nM. |
| Ensayo de quinasa |
Ensayos enzimáticos in vitro.
|
|
Todos los ensayos enzimáticos in vitro se realizan en Upstate Biotechnology, con la excepción de InsR e IGF-1R. Para determinar el IC50 de TAE684 (NVP-TAE684) contra InsR e IGF-1R, se realiza un ensayo de fluorescencia resuelta en el tiempo homogéneo. ATP (10 mM) y 20 mg/ml de PolyEY biotinilado (Glu, Tyr 4:1) se combinan con 50 nL de diluciones seriadas de este compuesto (10-500 nM) y 4 ng de enzima InsR en presencia del tampón de reacción de la quinasa (20 mM Tris-Cl, pH 7,5/10 mM MgCl2/3 mM MnCl2/1 mM DTT/10 mM NaVO4/0,1 mg/ml de BSA). Los ensayos se incuban durante 1 hora a temperatura ambiente. Las reacciones se terminan añadiendo 10 mL de la solución de detección que contiene 50 mM de EDTA, 500 mM de KF, 0,5 mg/ml de BSA, 5 mg/mL de anticuerpo anti-fosfotirosina Mab PT66-K marcado con criptato de Eu3+ y 5 mg/mL de estreptavidina-XLent. La reacción se incuba durante media hora y las señales de fluorescencia se leen en Analyst GT.
|
|
| In vivo |
Después de 4 semanas de tratamiento con TAE684 (NVP-TAE684) a 3 y 10 mg/kg, hay un retraso significativo en el desarrollo del linfoma y una reducción de 100 a 1.000 veces en la señal de luminiscencia, sin signos de toxicidad relacionada con el compuesto o la enfermedad en el modelo de linfoma de Karpas-299. Este tratamiento con el compuesto también induce la regresión de la enfermedad en linfomas Karpas-299 establecidos y regula a la baja la expresión de CD30. También muestra una impresionante actividad antitumoral contra tumores de xenoinjerto H3122 CR. Además, el tratamiento con este químico mejora el fenotipo de ojo rugoso de ambos mutantes de ALK, especialmente el observado con ALKR1275Q. |
Referencias |
|
| Métodos | Biomarcadores | Imágenes | PMID |
|---|---|---|---|
| Growth inhibition assay | Cell viability |
|
18594010 |
| Western blot | p-ROS1 / ROS1 p-ALK / ALK / p-STAT3 / STAT3 / p-ERK / ERK / p-AKT / AKT / Survivin / BIM / PARP |
|
25351743 |
Tel: +1-832-582-8158 Ext:3
Si tiene alguna otra consulta, por favor deje un mensaje.